Consolidated statement of cash flows

In € millions

Note

 

2017*

 

2018

*

Represented to present the Specialty Chemicals business as discontinued operations.

Profit for the period from con­tinuing oper­ations

 

511

 

455

 

 

 

 

 

 

 

Adjustments to reconcile earnings to cash generated from operating activities

 

 

 

 

 

Amortization and depreciation

10, 11

276

 

239

 

Impairment losses

10, 11

(4)

 

1

 

Financing income and expenses

7

78

 

52

 

Results from associates and joint ventures

12

(17)

 

(20)

 

Pre-tax result on acquisitions and divestments

2

(27)

 

(42)

 

Income tax

8

253

 

118

 

Changes in working capital

21

(105)

 

(177)

 

Changes in provisions

21

(338)

 

(203)

 

Interest paid

 

(81)

 

(89)

 

Income tax paid

 

(266)

 

(164)

 

Other changes

 

(2)

 

(8)

 

Net cash from operating activities

 

 

278

 

162

Capital expenditures

11

(250)

 

(160)

 

Interest received

 

12

 

47

 

Dividends from associates and joint ventures

 

7

 

7

 

Acquisition of consolidated companies

2

(80)

 

(128)

 

Investments in short-term investments

19

 

(5,541)

 

Repayments of short-term investments

19

 

80

 

Proceeds from divestments

 

41

 

54

 

Other changes

 

(14)

 

(27)

 

Net cash used for investing activities

 

 

(284)

 

(5,668)

Proceeds from borrowings

19

922

 

607

 

Borrowings repaid

19

(337)

 

(1,529)

 

Repurchase of shares

 

(160)

 

 

Dividends paid

 

(1,184)

 

(636)

 

Buy-out of non-controlling interests

 

 

(437)

 

Other changes

 

 

5

 

Net cash used for financing activities

 

 

(759)

 

(1,990)

 

 

 

 

 

 

Net cash used for Con­tinuing oper­ations

 

 

(765)

 

(7,496)

Net cash from discontinued operations

2

 

660

 

8,958

Net change in cash and cash equivalents of continued and Discon­tinued oper­ations

 

 

(105)

 

1,462

 

 

 

 

 

 

Net Cash and cash equivalents at January 1

19

 

1,441

 

1,278

Effect of exchange rate changes on cash and cash equivalents

 

 

(58)

 

(8)

Net cash and cash equivalents at December 31

 

 

1,278

 

2,732